{"Title": "Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES", "Year": 2017, "Source": "Mult. Scler.", "Volume": "23", "Issue": 4, "Art.No": null, "PageStart": 505, "PageEnd": 506, "CitedBy": 5, "DOI": "10.1177/1352458516671821", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85018697807&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85018697807", "SubjectAreas": [["Neurology", "NEUR", "2808"], ["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"57212501583": {"Name": "Chataway J.", "AuthorID": "57212501583", "AffiliationID": "60019953, 60022148, 60176027", "AffiliationName": "Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London"}}}